COVID vaccines: Novavax exec talks FDA approval process, supply chains, and pandemic outlook

Novavax Chief Business Officer John Trizzino joins Yahoo Finance Live to discuss the company awaiting an FDA approval for its COVID vaccine, supply chain constraints, and the outlook for COVID-19.